BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
See today's BioWorld Asia
Home
» In the clinic for Feb. 2-8, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
In the clinic for Feb. 2-8, 2021
Feb. 9, 2021
No Comments
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Agenus, Astrazeneca, Atea, Bioarctic, Biophytis, Botanix, Corvus, Covaxx, Daiichi Sankyo, Dong-A, Dynavax Technologies, Eiger, Eisai, Enlivex, Eucure, Glaxosmithkline, Golden, I-Mab, Innocare, Junshi, Neurorx, Reistone, Sanofi, Sinovac, Vaxart, Veru.
BioWorld Asia
Briefs
In the clinic